Back to Companies
Entrada Therapeutics, Inc.
TRDANasdaqCIK: 0001689375
Recent Form 4 activity at Entrada Therapeutics, Inc. (TRDA) spans 39 filings across 14 insiders (1 buying and 7 selling). Purchases total $1.6M against $15.0M in sales — heavily weighted toward selling, for net sales of $13.4M. PARMAR KUSH is the most active by dollar volume, and the single largest transaction was $2.8M by Doshi Dipal. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$23.6M
Purchases
$1.6M
Sales
$15.0M
Unique Insiders
14
Recent Insider Trades
39 loaded
| Sep 9 | TRDA Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $1.9M |
| Sep 9 | TRDA Entrada Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | Insider | Sell | $1.9M |
| Sep 3 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Tax withheld | $14.9K |
| Sep 3 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Tax withheld | $12.4K |
| Sep 3 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Tax withheld | $18.1K |
| Sep 3 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Tax withheld | $62.3K |
| Sep 3 | TRDA Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $617.4K |
| Sep 3 | TRDA Entrada Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | Insider | Sell | $617.4K |
| Aug 31 | TRDA Entrada Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | Insider | Sell | $615.8K |
| Aug 31 | TRDA Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $615.8K |
| Aug 26 | TRDA Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | Insider | Sell | $461.5K |
| Aug 26 | TRDA Entrada Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | Insider | Sell | $461.5K |
| Aug 10 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Insider | Sell | $1.1M |
| Aug 10 | TRDA Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | Insider | Sell | $431.8K |
| Aug 3 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Insider | Sell | $807.0K |
| Aug 3 | TRDA Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | Insider | Sell | $807.0K |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Director, 10% Owner | Award | $113.4K |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Thistle Mary | Director | Award | $113.4K |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Chapman Gina | Director | Award | $113.4K |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Radhakrishnan Maha | Director | Award | $113.4K |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Zeiher Bernhardt G | Director | Award | $113.4K |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | KIM PETER S | Director | Award | $113.4K |
| May 4 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Sell | $230.0K |
| May 4 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Sell | $398.8K |
| Mar 6 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $97.9K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Grant | $2.8M |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Grant | $1.1M |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Grant | $896.0K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Grant | $1.2M |
| Nov 24 | TRDA Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $261.8K |
| Nov 18 | TRDA Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | Insider | Sell | $1.8M |
| Nov 18 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Insider | Sell | $1.8M |
| Nov 12 | TRDA Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $1.4M |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Tax withheld | $47.4K |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Tax withheld | $9.5K |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Tax withheld | $9.6K |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Tax withheld | $9.4K |
| Jul 11 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Insider | Sell | $202.6K |
| Jul 11 | TRDA Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | Insider | Sell | $202.6K |
39 filings